Author

Nesrine Aboulhamid

Observed name: N Aboulhamid

Institution: McGill University

Observed institutions: McGill University Health Centre, McGill University

OpenAlex ID: A5041320177

Comparative Effectiveness of Ustekinumab and Anti-TNF Agent as First-Line Biological Therapy in Luminal Crohn’s Disease: A Retrospective Study From 2 Referral Centers

2022 · Pauline Rivière, Caitlyn Kanters, et al. · Inflammatory Bowel Diseases · 22

Rare Rectal Involvement of Metastatic Appendiceal Adenocarcinoma Mimicking Primary Rectal Cancer

2026 · Nesrine Aboulhamid, Amine Zoughlami, et al. · ACG Case Reports Journal

Mo1542: COMPARED EFFICACY OF USTEKINUMAB AND ANTI-TNF AGENTS AS FIRST-LINE BIOLOGICAL THERAPY IN LUMINAL CROHN’S DISEASE: A TWO-CENTER RETROSPECTIVE STUDY.

2022 · Pauline Rivière, Caitlyn Kanters, et al. · Gastroenterology

P524 Compared efficacy of ustekinumab and anti-TNF agents as first-line biological therapy in luminal Crohn’s disease

2022 · P Riviere, C Kanters, et al. · Journal of Crohn s and Colitis

Works count: 4

Citation count: 22

H-index: 1

I10-index: 1